Japan, Facing Rising Health Care Costs, May Slash Generic Drug Prices
This article was originally published in PharmAsia News
Japan may try to accelerate the increased usage of generic drugs by drastically reducing prices, part of an effort to slash skyrocketing health care costs at a time when the country’s public debt is reaching a record high.
You may also be interested in...
AstraZeneca KK’s young president Gabriel Baertschi is eying more partnerships for cardiovascular, oncology and respiratory therapies in Japan.
Kyowa Hakko Kirin is committed to expansion, and the deal with Ultragenyx for a first-in-class therapy of a rare bone disorder is small but establishes a clinical trial foothold overseas